Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.

Lagerlöf I, Holte H, Glimelius I, Björkholm M, Enblad G, Erlanson M, Fluge Ø, Fohlin H, Fosså A, Goldkuhl C, Gustavsson A, Johansson AS, Linderoth J, Nome O, Palma M, Åkesson L, Østenstad B, Raud C, Glimelius B, Molin D.

Br J Haematol. 2019 Oct 14. doi: 10.1111/bjh.16232. [Epub ahead of print]

PMID:
31612478
2.

PROXIMAL HUMERUS FRACTURE WITH LOCKING PLATE: FUNCTIONAL AND RADIOGRAPHIC RESULTS.

Petros RSB, Ribeiro FR, Tenor AC, Brasil R, Filardi CS, Molin DCD.

Acta Ortop Bras. 2019 May-Jun;27(3):164-168. doi: 10.1590/1413-785220192703142049.

3.

Electrical stimulation promotes the angiogenic potential of adipose-derived stem cells.

Beugels J, Molin DGM, Ophelders DRMG, Rutten T, Kessels L, Kloosterboer N, Grzymala AAP, Kramer BWW, van der Hulst RRWJ, Wolfs TGAM.

Sci Rep. 2019 Aug 19;9(1):12076. doi: 10.1038/s41598-019-48369-w.

4.

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.

Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH.

Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13.

PMID:
31409671
5.

Phosphodiester Hydrogels for Cell Scaffolding and Drug Release Applications.

Dera R, Diliën H, Billen B, Gagliardi M, Rahimi N, Van Den Akker NMS, Molin DGM, Grandfils C, Adriaensens P, Guedens W, Cleij TJ.

Macromol Biosci. 2019 Jul;19(7):e1900090. doi: 10.1002/mabi.201900090. Epub 2019 Jun 5.

PMID:
31166090
6.

Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy.

Pedersen MA, Gormsen LC, Kamper P, Wassberg C, Andersen MD, d'Amore AL, Barrington SF, Johnson P, Hamilton-Dutoit S, Amini RM, Enblad G, Molin D, d'Amore F.

Br J Haematol. 2019 Aug;186(3):431-439. doi: 10.1111/bjh.15933. Epub 2019 May 22.

PMID:
31115045
7.

Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival.

Lundberg J, Berglund D, Molin D, Kinch A.

Ups J Med Sci. 2019 Apr;124(2):105-110. doi: 10.1080/03009734.2018.1555195. Epub 2019 Mar 11.

8.

High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms.

Gholiha AR, Hollander P, Hedstrom G, Sundstrom C, Molin D, Smedby KE, Hjalgrim H, Glimelius I, Amini RM, Enblad G.

Br J Haematol. 2019 Jan;184(2):192-201. doi: 10.1111/bjh.15703. Epub 2018 Dec 2.

PMID:
30506671
9.

Synthesis of Functional Polymer Particles from Morita-Baylis-Hillman Polymerization.

Ramakers G, D'Incal C, Gagliardi M, Molin DGM, Junkers T.

Macromol Rapid Commun. 2018 Dec;39(23):e1800678. doi: 10.1002/marc.201800678. Epub 2018 Nov 2.

PMID:
30387221
10.

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease.

Bergqvist V, Kadivar M, Molin D, Angelison L, Hammarlund P, Olin M, Torp J, Grip O, Nilson S, Hertervig E, Lillienau J, Marsal J.

Therap Adv Gastroenterol. 2018 Oct 11;11:1756284818801244. doi: 10.1177/1756284818801244. eCollection 2018.

11.

Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma.

Hollander P, Amini RM, Ginman B, Molin D, Enblad G, Glimelius I.

PLoS One. 2018 Sep 27;13(9):e0204870. doi: 10.1371/journal.pone.0204870. eCollection 2018.

12.

Extracellular Vesicles Work as a Functional Inflammatory Mediator Between Vascular Endothelial Cells and Immune Cells.

Hosseinkhani B, Kuypers S, van den Akker NMS, Molin DGM, Michiels L.

Front Immunol. 2018 Aug 6;9:1789. doi: 10.3389/fimmu.2018.01789. eCollection 2018.

13.

Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome?

Mörth C, Valachis A, Sabaa AA, Molin D, Flogegård M, Enblad G.

Ann Hematol. 2018 Nov;97(11):2129-2135. doi: 10.1007/s00277-018-3437-z. Epub 2018 Aug 8.

14.

Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation.

Kinch A, Sundström C, Baecklund E, Backlin C, Molin D, Enblad G.

Leuk Lymphoma. 2019 Feb;60(2):376-384. doi: 10.1080/10428194.2018.1480767. Epub 2018 Jul 22.

PMID:
30033844
15.

Maintaining bovine satellite cells stemness through p38 pathway.

Ding S, Swennen GNM, Messmer T, Gagliardi M, Molin DGM, Li C, Zhou G, Post MJ.

Sci Rep. 2018 Jul 17;8(1):10808. doi: 10.1038/s41598-018-28746-7.

16.

High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome.

Hollander P, Kamper P, Smedby KE, Enblad G, Ludvigsen M, Mortensen J, Amini RM, Hamilton-Dutoit S, d'Amore F, Molin D, Glimelius I.

Blood Adv. 2017 Aug 8;1(18):1427-1439. doi: 10.1182/bloodadvances.2017006346. eCollection 2017 Aug 8.

17.

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.

Hollander P, Rostgaard K, Smedby KE, Molin D, Loskog A, de Nully Brown P, Enblad G, Amini RM, Hjalgrim H, Glimelius I.

Eur J Haematol. 2018 Jan;100(1):88-97. doi: 10.1111/ejh.12987. Epub 2017 Nov 14.

PMID:
29064587
18.

Hodgkin lymphoma in children, adolescents and young adults - a comparative study of clinical presentation and treatment outcome.

Englund A, Glimelius I, Rostgaard K, Smedby KE, Eloranta S, Molin D, Kuusk T, Brown PN, Kamper P, Hjalgrim H, Ljungman G, Hjalgrim LL.

Acta Oncol. 2018 Feb;57(2):276-282. doi: 10.1080/0284186X.2017.1355563. Epub 2017 Aug 1.

PMID:
28760045
19.

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087.

J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25.

20.

Direct detection of nano-scale extracellular vesicles derived from inflammation-triggered endothelial cells using surface plasmon resonance.

Hosseinkhani B, van den Akker N, D'Haen J, Gagliardi M, Struys T, Lambrichts I, Waltenberger J, Nelissen I, Hooyberghs J, Molin DGM, Michiels L.

Nanomedicine. 2017 Jul;13(5):1663-1671. doi: 10.1016/j.nano.2017.03.010. Epub 2017 Mar 30.

Supplemental Content

Support Center